SPDYE18
gene geneOn this page
Summary
SPDYE18 (speedy/RINGO cell cycle regulator family member E18, HGNC:51514) is a protein-coding gene on chromosome 7q11.23, encoding Speedy protein E18 (P0DV79).
Predicted to enable protein kinase binding activity.
Source: NCBI Gene 100505767 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001394953
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:51514 |
| Approved symbol | SPDYE18 |
| Name | speedy/RINGO cell cycle regulator family member E18 |
| Location | 7q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000205482 |
| Ensembl biotype | protein_coding |
| Entrez | 100505767 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000510091, ENST00000965050
RefSeq mRNA: 2 — MANE Select: NM_001394953
NM_001351348, NM_001394953
CCDS: CCDS94131
Canonical transcript exons
ENST00000510091 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002019255 | 77059180 | 77059398 |
| ENSE00002022364 | 77052733 | 77052837 |
| ENSE00002030601 | 77057637 | 77057867 |
| ENSE00002063887 | 77055236 | 77055321 |
| ENSE00002069463 | 77056550 | 77056608 |
| ENSE00003799859 | 77052960 | 77053203 |
| ENSE00003919469 | 77060353 | 77060933 |
| ENSE00003932588 | 77062496 | 77062558 |
| ENSE00003935105 | 77050391 | 77051879 |
Expression profiles
Bgee: expression breadth ubiquitous, 130 present calls, max score 65.27.
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| popliteal artery | UBERON:0002250 | 65.27 | gold quality |
| tibial artery | UBERON:0007610 | 65.23 | gold quality |
| left ovary | UBERON:0002119 | 64.81 | gold quality |
| ovary | UBERON:0000992 | 64.36 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 64.36 | gold quality |
| mucosa of stomach | UBERON:0001199 | 64.16 | gold quality |
| left testis | UBERON:0004533 | 64.04 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 64.03 | gold quality |
| testis | UBERON:0000473 | 64.02 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 63.99 | gold quality |
| right ovary | UBERON:0002118 | 63.97 | gold quality |
| right testis | UBERON:0004534 | 63.78 | gold quality |
| thyroid gland | UBERON:0002046 | 63.04 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 62.92 | gold quality |
| cerebellum | UBERON:0002037 | 62.42 | gold quality |
| cerebellar cortex | UBERON:0002129 | 62.40 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 62.37 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 62.33 | gold quality |
| gastrocnemius | UBERON:0001388 | 62.27 | gold quality |
| muscle of leg | UBERON:0001383 | 62.17 | gold quality |
| muscle tissue | UBERON:0002385 | 61.62 | gold quality |
| tibial nerve | UBERON:0001323 | 61.60 | gold quality |
| right uterine tube | UBERON:0001302 | 61.29 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 61.27 | gold quality |
| lower esophagus | UBERON:0013473 | 61.15 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 61.15 | gold quality |
| duodenum | UBERON:0002114 | 61.10 | gold quality |
| left coronary artery | UBERON:0001626 | 60.88 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 60.78 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 60.56 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.85 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spdye4b | ENSMUSG00000029586 |
| mus_musculus | Spdye4a | ENSMUSG00000039296 |
| rattus_norvegicus | Spdye4 | ENSRNOG00000058563 |
Paralogs (18): SPDYE1 (ENSG00000136206), SPDYE5 (ENSG00000170092), SPDYE2B (ENSG00000173678), SPDYE4 (ENSG00000183318), SPDYE12 (ENSG00000184616), SPDYE16 (ENSG00000185040), SPDYE17 (ENSG00000186645), SPDYE2 (ENSG00000205238), SPDYE3 (ENSG00000214300), SPDYE21 (ENSG00000230358), SPDYE6 (ENSG00000260097), SPDYE9 (ENSG00000262461), SPDYE8 (ENSG00000273520), SPDYE10 (ENSG00000274570), SPDYE11 (ENSG00000275976), SPDYE15 (ENSG00000286014), SPDYE13 (ENSG00000286038), SPDYE14 (ENSG00000286137)
Protein
Protein identifiers
Speedy protein E18 — P0DV79 (reviewed: P0DV79)
All UniProt accessions (2): P0DV79, A0A8I5KS96
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the Speedy/Ringo family.
RefSeq proteins (2): NP_001338277, NP_001381882* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR020984 | Speedy | Family |
| IPR057742 | Speedy_E | Family |
Pfam: PF11357
UniProt features (5 total): compositionally biased region 3, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DV79-F1 | 61.63 | 0.28 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 8 (showing top):
chr7q11, GOMF_KINASE_BINDING, GSE14350_TREG_VS_TEFF_DN, GSE27786_LSK_VS_CD4_TCELL_DN, GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_UP, GSE4142_NAIVE_VS_MEMORY_BCELL_UP, GSE6875_TCONV_VS_TREG_UP, GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_DN
GO Biological Process (1): positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)
GO Molecular Function (1): protein kinase binding (GO:0019901)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of cyclin-dependent protein serine/threonine kinase activity | 1 |
| cyclin-dependent protein serine/threonine kinase activity | 1 |
| positive regulation of cell cycle | 1 |
| positive regulation of protein serine/threonine kinase activity | 1 |
| positive regulation of cyclin-dependent protein kinase activity | 1 |
| kinase binding | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0J9YX94, A0A0J9YXQ4, A0A0J9YY54, A0A494C1R9, A1L443, A5D7L8, A6NDY0, A6NKD2, E9PGG2, F6SZT2, O19110, O75807, O88852, P0CV98, P0CV99, P0CW00, P0CW01, P0CW24, P0DV79, P17564, P59644, P78358, Q01534, Q0P5N2, Q15735, Q2KI51, Q587J8, Q5R5G8, Q5R6R8, Q5RFC2, Q5SV97, Q60465, Q6P752, Q86V59, Q8BSI6, Q8N9W4, Q8NAG6, Q8NEE8, Q8VD63, Q95LS7
Diamond homologs: A0A494C086, A0A494C0Z2, A0A494C191, A6NHP3, A6NIY4, A6NJR5, A6NKU9, A6NLX3, A6NNV3, P0CI01, P0DTA3, P0DUD1, P0DUD2, P0DUD3, P0DUD4, P0DUX0, P0DUX1, P0DV79, Q495Y7, Q495Y8, Q5IBH6, Q5IBH7, Q5MJ68, Q5MJ70, Q8NFV5, Q8R496, Q9PU13, Q9YGL1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
2320 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000197874 (7:77053832 CTA>C), RS1000804650 (7:77058861 T>C), RS1001570351 (7:77060508 T>C), RS1002210621 (7:77060412 C>T), RS1002815715 (7:77062302 G>A), RS1003352887 (7:77053442 C>G), RS1003499751 (7:77050334 A>T), RS1003557118 (7:77064479 T>A), RS1003592166 (7:77052131 T>C), RS1004225007 (7:77063440 C>T), RS1004464341 (7:77057344 T>G), RS1004602031 (7:77058030 C>T), RS1005469758 (7:77059544 T>C), RS1005605655 (7:77060007 C>A,G,T), RS1006963683 (7:77061319 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| abrine | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Lactic Acid | increases expression | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.